本页面由Tiger Trade Technology Pte. Ltd.提供服务

NGM Biopharmaceuticals Inc

1.54
0.0000
成交量:- -
成交额:370.46万
市值:1.29亿
市盈率:-0.89
高:1.54
开:1.54
低:1.54
收:1.54
52周最高:4.69
52周最低:0.6002
股本:8,346.24万
流通股本:2,888.64万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.7258
每股收益(LYR):-1.7258
净资产收益率:-69.76%
总资产收益率:-38.46%
市净率:0.86
市盈率(LYR):-0.89

数据加载中...

2019/06/21

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/21

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/06

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/06

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/06

持股变动声明

Statement of changes in beneficial ownership of securities
2019/05/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/16

重要事件披露

Current report, items 2.02 and 9.01
2019/05/16

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/04/08

重要事件披露

Current report, items 3.02, 5.03, and 9.01
2019/04/01

SEC问询函

[Cover]Correspondence
2019/04/01

SEC问询函

[Cover]Correspondence
2019/04/01

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/04/01

SEC问询函

[Cover]Correspondence
2019/03/25

SEC问询函

[Cover]Correspondence